Publicaciones en colaboración con investigadores/as de Stanford University School of Medicine (6)

2022

  1. Killers on the loose: Immunotherapeutic strategies to improve NK cell-based therapy for cancer treatment

    International Review of Cell and Molecular Biology (Elsevier Inc.), pp. 65-122

2018

  1. Immunotherapy targeting 4-1BB: Mechanistic rationale, clinical results, and future strategies

    Blood, Vol. 131, Núm. 1, pp. 49-57

2017

  1. Results from an integrated safety analysis of urelumab, an agonist anti-CD137 monoclonal antibody

    Clinical Cancer Research, Vol. 23, Núm. 8, pp. 1929-1936

2016

  1. Defining the optimal murine models to investigate immune checkpoint blockers and their combination with other immunotherapies

    Annals of Oncology, Vol. 27, Núm. 7, pp. 1190-1198

  2. Immunodynamics: A cancer immunotherapy trials network review of immune monitoring in immuno-oncology clinical trials

    Journal for ImmunoTherapy of Cancer, Vol. 4, Núm. 1

2012

  1. Liver Gene Transfer of Interkeukin-15 Constructs That Become Part of Circulating High Density Lipoproteins for Immunotherapy

    PLoS ONE, Vol. 7, Núm. 12